StockData
Olema Oncology, Inc. logo

Olema Oncology, Inc. (OLMA) stock

OLMANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/30
$7.22−0.14 (-1.90%)

Close on Nov 17, 2026Market cap $631.73MP/E –Yield –

Olema Oncology price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Olema Oncology's price to book ratio was 1.6× on Nov 11, 2026, against 6.3× a year earlier. Over the last 5 years it ranged from 0.4× to 6.3×, with a median of 1.8×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.6×−3.9
2025Dec 31, 20255.6×+3.9
2024Dec 31, 20241.7×−1.1
2023Dec 29, 20232.8×+2.3
2022Dec 30, 20220.5×−0.8
2021Dec 31, 20211.2×–

More Olema Oncology figures

See a number that looks wrong?